| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec5b8c0fc1f827c1360a8f5ea5652225 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2013-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640938bbb7df2b00c23b0535eb0c668a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04e4b0fa2329e57a2e73b828b790bd56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07ac695ba373a8f81035d136e68b532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc6ab3086a8386a35becbe10a479553 |
| publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102013011634-A1 |
| titleOfInvention |
A method for the quantitative characterization of amyloid peptides and / or proteins in a sample |
| abstract |
The invention relates to a method for the quantitative characterization of amyloid peptides and / or proteins in a sample, comprising the following steps: a sample is provided, the sample comprising an amyloid peptide and / or protein having at least one aggregate size and shape, An active substance to be tested is added to the sample solution, the amyloid peptides and / or proteins are separated with respect to their aggregate size and shape, the amyloid peptides and / or proteins of a certain fraction are completely denatured to form monomer units, Concentration of the amyloid peptide and / or protein monomer building blocks is determined in each desired fraction by comparison with control values without the active ingredient. |
| priorityDate |
2013-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |